Immune checkpoint inhibitors retain effectiveness in older patients with cutaneous metastatic melanoma.

Immune checkpoint inhibitors retain effectiveness in older patients with cutaneous metastatic melanoma. J Geriatr Oncol. 2021 04; 12(3):394-401.

View in: PubMed